Is a matched unrelated donor search needed for all allogeneic transplant candidates?
暂无分享,去创建一个
M. Konopleva | U. Popat | Q. Bashir | R. Champlin | D. Milton | R. Mehta | G. Rondón | C. Hosing | P. Kebriaei | I. Khouri | B. Oran | S. Ciurea | Julianne J Chen | Jin S Im | P. Kongtim | K. Cao | G. Al-Atrash | J. M. R. Perez | M. C. B. Bittencourt | M. E. El Shazly | Majdi Aljadayeh | M. Alvarez | G. Rondon | Piyanuch Kongtim
[1] M. Solh,et al. Donor Type and Disease Risk Predict the Success of Allogeneic Hematopoietic Cell Transplantation: A Single-Center Analysis of 613 Adult Hematopoietic Cell Transplantation Recipients Using a Modified Composite Endpoint. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[2] B. Sandmaier,et al. Comparing outcomes of matched related donor and matched unrelated donor hematopoietic cell transplants in adults with B‐Cell acute lymphoblastic leukemia , 2017, Cancer.
[3] J. Esteve,et al. Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT , 2017, Journal of Hematology & Oncology.
[4] S. Montoto,et al. Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report , 2017, Bone Marrow Transplantation.
[5] S. Davies,et al. How Long Does it Take to Find a Matched Unrelated Donor in 2016 , 2017 .
[6] Hongkun Wang,et al. Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[7] A. Gennery,et al. Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually , 2016, Bone Marrow Transplantation.
[8] Y. Kodera,et al. Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey , 2016, Bone Marrow Transplantation.
[9] Sonali M. Smith,et al. Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors. , 2016, Blood.
[10] R. Bouabdallah,et al. Haploidentical T Cell-Replete Transplantation with Post-Transplantation Cyclophosphamide for Patients in or above the Sixth Decade of Age Compared with Allogeneic Hematopoietic Stem Cell Transplantation from an Human Leukocyte Antigen-Matched Related or Unrelated Donor. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[11] R. Vij,et al. Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia. , 2015, Blood.
[12] Karl Frauendorfer,et al. One million haemopoietic stem-cell transplants: a retrospective observational study. , 2015, The Lancet. Haematology.
[13] M. Konopleva,et al. Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen-matched unrelated and related donors. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[14] M. Gobbi,et al. Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[15] Loren Gragert,et al. HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry. , 2014, The New England journal of medicine.
[16] M. Schell,et al. Race/ethnicity affects the probability of finding an HLA-A, -B, -C and -DRB1 allele-matched unrelated donor and likelihood of subsequent transplant utilization , 2013, Bone Marrow Transplantation.
[17] S. Solomon,et al. T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] Tao Wang,et al. Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders. , 2012, Blood.
[19] M. Horowitz,et al. Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia. , 2012, Blood.
[20] R. Champlin,et al. Progress in haploidentical stem cell transplantation. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[21] Y. Kodera,et al. Worldwide network for blood and marrow transplantation , 2009 .
[22] M. Maris,et al. Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphoma. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[23] K. Ballen,et al. The national marrow donor program 20 years of unrelated donor hematopoietic cell transplantation. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[24] S. Spellman,et al. National marrow donor program HLA matching guidelines for unrelated adult donor hematopoietic cell transplants. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[25] F. Appelbaum. Allogeneic hematopoietic cell transplantation for acute myeloid leukemia when a matched related donor is not available. , 2008, Hematology. American Society of Hematology. Education Program.
[26] Harriet Noreen,et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. , 2007, Blood.
[27] Edward A Copelan,et al. Hematopoietic stem-cell transplantation. , 2006, The New England journal of medicine.
[28] Harriet Noreen,et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. , 2004, Blood.
[29] A. Hagenbeek,et al. Cost analysis of HLA-identical sibling and voluntary unrelated allogeneic bone marrow and peripheral blood stem cell transplantation in adults with acute myelocytic leukaemia or acute lymphoblastic leukaemia , 2002, Bone Marrow Transplantation.